微小RNA-218-5p通过调控PGC-1α影响脓毒症诱导急性肾损伤线粒体生物合成机制
该研究通过盲肠结扎穿孔建立脓毒症诱导急性肾损伤(SI-AKI)小鼠模型,用PGC-1α激活剂ZLN005预处理后观察肾组织病理、凋亡及线粒体功能,并在脂多糖处理的HK2细胞中验证。结果显示PGC-1α在SI-AKI中低表达,ZLN005激活PGC-1α可减轻SI-AKI损伤、促进线粒体生物合成并缓解LPS诱导的细胞损伤;PGC-1α是miR-218-5p的靶点,下调miR-218-5p可减轻HK2细胞线粒体生物合成障碍,抑制PGC-1α则取消该作用;体内过表达miR-218-5p部分逆转ZLN005的保护作用。结论为miR-218-5p靶向PGC-1α破坏线粒体生物合成,从而加重SI-AKI。
要点
- 在盲肠结扎穿孔SI-AKI小鼠中,PGC-1α低表达,用ZLN005激活PGC-1α可减轻SI-AKI损伤并促进线粒体生物合成。
- 在LPS处理的HK2细胞中,下调miR-218-5p可减轻线粒体生物合成障碍,抑制PGC-1α则取消该保护作用。
- PGC-1α被验证为miR-218-5p的靶点,miR-218-5p通过靶向PGC-1α破坏线粒体生物合成而加重SI-AKI。
- 在ZLN005预处理的SI-AKI小鼠中过表达miR-218-5p,可部分逆转ZLN005的保护作用。
- 上述结果来自小鼠模型与HK2细胞实验,尚未提供急诊或ICU床旁可直接应用的诊断阈值或药物剂量方案。
适用人群与场景
- 盲肠结扎穿孔建立的脓毒症诱导急性肾损伤小鼠模型。
- 脂多糖处理模拟脓毒症的HK2细胞体外模型。
处置流程与药物剂量
- 在收集血清和组织样本前,使用PGC-1α激活剂ZLN005预处理SI-AKI小鼠以激活PGC-1α表达,原文未写明ZLN005的剂量、给药途径和疗程。
研究设计与关键结果
- 研究类型为动物实验与细胞实验;SI-AKI小鼠经盲肠结扎穿孔建立,PGC-1α在SI-AKI中低表达,用ZLN005过表达PGC-1α可减轻SI-AKI损伤、促进线粒体生物合成,并缓解LPS诱导的细胞损伤。
- PGC-1α被验证为miR-218-5p的靶点;在HK2细胞中下调miR-218-5p可减轻线粒体生物合成障碍,抑制PGC-1α则取消miR-218-5p沉默的作用。
- 体内实验中,过表达miR-218-5p可部分逆转ZLN005对SI-AKI小鼠的保护作用。
证据类型、等级与局限
- 证据类型:动物实验与细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论为miR-218-5p靶向PGC-1α破坏线粒体生物合成,从而加重SI-AKI;该机制来自小鼠与HK2细胞实验,原文未据此给出急诊或ICU临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Sepsis-induced acute kidney injury (SI-AKI) is a kind of kidney dysfunction, which brings a lot of suffering. This study aimed to figure out the role of the miR-218-5p/PGC-1α axis in SI-AKI. Methods: AKI mouse model was established through cecal ligation and puncture. PGC-1α expression was activated using an activator ZLN005 before the serum and tissue samples were collected. Next, pathological structure and apoptosis of kidney tissues were observed. Levels of blood urea nitrogen, serum creatinine, and indicators of inflammation and oxidative stress were assessed. Moreover, reactive oxygen species and mitochondrial membrane potential levels, adenosine 5'-triphosphate content, and mitochondrial ultrastructure of kidney tissues were observed. HK2 cells were treated by lipopolysaccharide (LPS) to mimic sepsis in vitro , followed by evaluation of cell survival and apoptosis, inflammation, and oxidative stress. Subsequently, the binding relation between PGC-1α and miR-218-5p was predicted and validated. Then expression of PGC-1α and miR-218-5p was detected. PGC-1α and miR-218-5p expression were intervened to detect their influences in mitochondrial biogenesis. At last, miR-218-5p was overexpressed in ZLN005 (PGC-1α activating agent) pretreated SI-AKI mice to validate the mechanism. Results: PGC-1α is poorly expressed in SI-AKI, but overexpression of PGC-1α using ZLN005 alleviated SI-AKI injury and promoted mitochondrial biogenesis in AKI mice, and relieved LPS-induced cell injury. PGC-1α is a target of miR-218-5p. Downregulation of miR-218-5p expression in HK2 cells attenuated mitochondrial biogenesis disorder. Inhibition of PGC-1α annulled the role of miR-218-5p silencing in cells. In vivo , miR-218-5p overexpression partly reversed the protective role of ZLN005 in SI-AKI mice. Conclusion: miR-218-5p targeted PGC-1α to disrupt mitochondrial biogenesis, thereby exacerbating SI-AKI.
参考来源
- Kuang J, Fang J, Hu S, et al. MECHANISM OF MICRORNA-218-5P IN MITOCHONDRIAL BIOGENESIS OF SEPSIS-INDUCED ACUTE KIDNEY INJURY BY THE REGULATION OF PGC-1Α. Shock. 2024. PMID: 38888503. doi:10.1097/SHK.0000000000002410
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。